(CVSB) Morgan Stanley Trust - Overview
Etf: Ultra-Short, Investment-Grade, Fixed-Income, Floating-Rate
Dividends
| Dividend Yield | 4.66% |
| Yield on Cost 5y | 5.49% |
| Yield CAGR 5y | -1.93% |
| Payout Consistency | 96.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 1.53% |
| Relative Tail Risk | -19.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.67 |
| Alpha | 0.83 |
| Character TTM | |
|---|---|
| Beta | -0.002 |
| Beta Downside | -0.011 |
| Drawdowns 3y | |
|---|---|
| Max DD | 0.63% |
| CAGR/Max DD | 9.08 |
Description: CVSB Morgan Stanley Trust January 25, 2026
The Calvert Ultra Short Investment Grade ETF (NYSE ARCA: CVSB) aims to preserve capital and generate modest income by allocating at least 80% of its net assets-plus any investment-purpose borrowings-to a diversified mix of investment-grade, short-term fixed-rate, variable-rate, and floating-rate securities. As an actively managed fund, it does not track a benchmark and therefore has flexibility in security selection within the ultra-short bond space.
As of the latest reporting (January 2026):
• 30-day SEC yield: 2.12%, reflecting current short-term credit spreads and a Federal Reserve policy rate near 5.25%-5.50%.
• Weighted average maturity: 0.68 years, indicating a very short duration that limits interest-rate risk.
• Assets under management (AUM): ≈ $1.3 billion, with an expense ratio of 0.25%, positioning the fund among the lower-cost options in the ultra-short bond category.
These figures suggest the ETF is sensitive to changes in the Fed’s policy stance and corporate credit conditions, especially in the financials and industrials sectors that dominate the short-term investment-grade market.
For a deeper dive into CVSB’s risk-adjusted performance and sector exposures, you might explore the analytics on ValueRay.
What is the price of CVSB shares?
Over the past week, the price has changed by +0.07%, over one month by +0.36%, over three months by +1.18% and over the past year by +4.87%.
Is CVSB a buy, sell or hold?
What are the forecasts/targets for the CVSB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 55 | 8.3% |
CVSB Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 182.6m USD (182.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 182.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 182.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.91% (E(182.6m)/V(182.6m) * Re(5.91%) + (debt-free company))
Discount Rate = 5.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)